Safety and efficacy of standard of care ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM): real world experience

Sidana, S; Patel, K; Peres, L; Bansal, R; Kocoglu, MH; Shune, L; Atrash, S; Smith, K; Ferreri, C; Dhakal, B; Chhabra, S; Parrondo, R; Costello, P; Midha, S; Martin, T; Simmons, G; Alsina, M; Htut, M; Voorhees, P; Sborov, D; Khouri, J; Wong, S; Janakiram, M; Lin, Y; Hansen, D

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023; 23 (): S61